Clinical Trials Directory

Trials / Completed

CompletedNCT01531049

Smoking Habits and Smoking Cessation in Young Adults

Smoking Cessation in Young Adults in Northern Finland

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Tuula Toljamo · Academic / Other
Sex
All
Age
18 Years – 26 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the efficacy and effectiveness of varenicline and nicotine patch combined with motivational interview technique in smoking cessation of young adults over 12 months follow-up.

Detailed description

Most teenage smokers are still smoking when they become adults confirming that stopping of smoking at young age is difficult although majority of young smokers want to quit. Young smokers experience many relapses partly due to the lack of appropriate and available cessation services. The discomfort experienced during cessation attempts is likely to be negatively associated with cessation success. Quitting of smoking is by the far most important procedure in preventing COPD progression. In Finland, 18-35% of young adults smoke, the variability being associated at least with socioeconomic background, education and geographical area. Our recent studies on male military draftees have shown that smoking is much more frequent in Northern than Southern Finland. However young men want to quit and accept new smoking restrictions. Very few studies are available on quitting attempts or counselling, pharmacotherapy and/or their combinations in young adults who want to quit.

Conditions

Interventions

TypeNameDescription
DRUGvareniclinedays 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day
DRUGNicotine cutaneous patch 15mg/16hOne patch for 16hours/day and duration of 8 weeks.
DRUGNicotine cutaneous patch 10mg/16hOne patch 16hours/day and duration of 8 weeks
OTHERPlacebo cutaneous patchNo active medication.O ne patch 16hours and duration for 8 weeks

Timeline

Start date
2012-05-01
Primary completion
2015-12-31
Completion
2016-09-02
First posted
2012-02-10
Last updated
2017-06-05

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01531049. Inclusion in this directory is not an endorsement.